AT361902B - Verfahren zur herstellung von neuen amino- saeurederivaten sowie deren salzen und optisch aktiven antipoden - Google Patents

Verfahren zur herstellung von neuen amino- saeurederivaten sowie deren salzen und optisch aktiven antipoden

Info

Publication number
AT361902B
AT361902B AT314075A AT314075A AT361902B AT 361902 B AT361902 B AT 361902B AT 314075 A AT314075 A AT 314075A AT 314075 A AT314075 A AT 314075A AT 361902 B AT361902 B AT 361902B
Authority
AT
Austria
Prior art keywords
salts
amino acid
optically active
acid derivatives
producing new
Prior art date
Application number
AT314075A
Other languages
German (de)
English (en)
Other versions
ATA314075A (de
Inventor
Laszlo Chem Ing Feuer
Arpad Chem Ing Furka
Ferenc Chem Ing Sebestyen
Jolan Chem Ing Hercsel
Erzsebet Bendefy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU74FE00000928A external-priority patent/HU171576B/hu
Priority claimed from HU74CI1558A external-priority patent/HU174114B/hu
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of ATA314075A publication Critical patent/ATA314075A/de
Application granted granted Critical
Publication of AT361902B publication Critical patent/AT361902B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT314075A 1974-04-29 1975-04-24 Verfahren zur herstellung von neuen amino- saeurederivaten sowie deren salzen und optisch aktiven antipoden AT361902B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU74FE00000928A HU171576B (hu) 1974-04-29 1974-04-29 Sposob otdelenija gamma-l-glutamil-taurina
HU74CI1558A HU174114B (hu) 1975-03-26 1975-03-26 Sposob poluchenija novykh proizvodnykh aminokislot

Publications (2)

Publication Number Publication Date
ATA314075A ATA314075A (de) 1980-09-15
AT361902B true AT361902B (de) 1981-04-10

Family

ID=26318406

Family Applications (6)

Application Number Title Priority Date Filing Date
AT314075A AT361902B (de) 1974-04-29 1975-04-24 Verfahren zur herstellung von neuen amino- saeurederivaten sowie deren salzen und optisch aktiven antipoden
AT624777A Expired AT359084B (de) 1974-04-29 1977-08-30 Verfahren zur herstellung neuer n-aralkoxy- carbonylaminosaeurederivate sowie ihrer salze und optischen antipoden
AT624877A AT359085B (de) 1974-04-29 1977-08-30 Verfahren zur herstellung neuer aminosaeure- amide, ihrer salze und optisch aktiven antipoden
AT624977A AT351007B (de) 1974-04-29 1977-08-30 Verfahren zur herstellung neuer aminosaeure- derivate
AT0323079A AT374484B (de) 1974-04-29 1979-04-30 Verfahren zur herstellung neuer aminosaeurederivate, deren salzen und optischen antipoden
AT0323179A AT370724B (de) 1974-04-29 1979-04-30 Verfahren zur herstellung neuer aminosaeurederivate, deren salzen und optischen antipoden

Family Applications After (5)

Application Number Title Priority Date Filing Date
AT624777A Expired AT359084B (de) 1974-04-29 1977-08-30 Verfahren zur herstellung neuer n-aralkoxy- carbonylaminosaeurederivate sowie ihrer salze und optischen antipoden
AT624877A AT359085B (de) 1974-04-29 1977-08-30 Verfahren zur herstellung neuer aminosaeure- amide, ihrer salze und optisch aktiven antipoden
AT624977A AT351007B (de) 1974-04-29 1977-08-30 Verfahren zur herstellung neuer aminosaeure- derivate
AT0323079A AT374484B (de) 1974-04-29 1979-04-30 Verfahren zur herstellung neuer aminosaeurederivate, deren salzen und optischen antipoden
AT0323179A AT370724B (de) 1974-04-29 1979-04-30 Verfahren zur herstellung neuer aminosaeurederivate, deren salzen und optischen antipoden

Country Status (23)

Country Link
JP (1) JPS6012347B2 (US07534539-20090519-C00280.png)
AR (3) AR217236A1 (US07534539-20090519-C00280.png)
AT (6) AT361902B (US07534539-20090519-C00280.png)
AU (1) AU499173B2 (US07534539-20090519-C00280.png)
BE (1) BE828546A (US07534539-20090519-C00280.png)
BG (4) BG26517A4 (US07534539-20090519-C00280.png)
CA (1) CA1051802A (US07534539-20090519-C00280.png)
CH (4) CH617183A5 (US07534539-20090519-C00280.png)
CS (4) CS209855B2 (US07534539-20090519-C00280.png)
DD (2) DD125070A5 (US07534539-20090519-C00280.png)
DE (2) DE2518160A1 (US07534539-20090519-C00280.png)
DK (10) DK155433C (US07534539-20090519-C00280.png)
EG (1) EG11847A (US07534539-20090519-C00280.png)
ES (4) ES436986A1 (US07534539-20090519-C00280.png)
FI (1) FI65990C (US07534539-20090519-C00280.png)
FR (1) FR2279388A1 (US07534539-20090519-C00280.png)
GB (1) GB1504541A (US07534539-20090519-C00280.png)
IL (1) IL47149A (US07534539-20090519-C00280.png)
NL (1) NL183186C (US07534539-20090519-C00280.png)
NO (2) NO146430C (US07534539-20090519-C00280.png)
PL (2) PL111746B1 (US07534539-20090519-C00280.png)
SE (2) SE430164B (US07534539-20090519-C00280.png)
SU (1) SU747419A3 (US07534539-20090519-C00280.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178199B (en) * 1976-05-06 1982-03-28 Chinoin Gyogyszer Es Vegyeszet New process for producing amides of omega-amino-carboxylic acids
HU180443B (en) * 1979-04-02 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a pharmaceutical preparation with synergetic action against radiation
HU185632B (en) * 1981-03-27 1985-03-28 Chinoin Gyogyszer Es Vegyeszet New process for preparing gamma-glutamyl-taurine
CH665645A5 (fr) * 1981-07-09 1988-05-31 Michel Flork Derives de dipeptides et leur procede de preparation.
HU208072B (en) * 1990-02-28 1993-08-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for preventing and curing autoimmune diseases and skin affections caused by heat and light radiacion
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤
JPH11180846A (ja) * 1997-12-15 1999-07-06 Sogo Pharmaceut Co Ltd 化粧料
DE10133197A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
US9662304B1 (en) * 2013-06-13 2017-05-30 Thermolife International, Llc Substituted glutaurine compounds and substituted glutaurine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169462B (US07534539-20090519-C00280.png) * 1971-08-04 1976-11-28

Also Published As

Publication number Publication date
ATA314075A (de) 1980-09-15
AR218222A1 (es) 1980-05-30
BG26517A4 (bg) 1979-04-12
DK159654C (da) 1991-04-08
CH621333A5 (US07534539-20090519-C00280.png) 1981-01-30
DK158676C (da) 1991-01-14
BG26368A3 (bg) 1979-03-15
DK155732C (da) 1989-10-02
PL111746B1 (en) 1980-09-30
DK155433C (da) 1989-10-16
AU499173B2 (en) 1979-04-05
NO146430C (no) 1982-09-29
AU8056475A (en) 1976-11-04
NO810816L (no) 1975-10-30
CH617183A5 (US07534539-20090519-C00280.png) 1980-05-14
DK245783D0 (da) 1983-05-31
ATA323079A (de) 1983-09-15
ATA323179A (de) 1982-09-15
DK155520B (da) 1989-04-17
DK182875A (da) 1975-10-30
DK442877A (da) 1977-10-06
IL47149A (en) 1979-05-31
DK155732B (da) 1989-05-08
AR218221A1 (es) 1980-05-30
AT370724B (de) 1983-04-25
CS209857B2 (en) 1981-12-31
DK442477A (da) 1977-10-06
FI65990C (fi) 1984-08-10
AT351007B (de) 1979-07-10
BG26370A4 (bg) 1979-03-15
DD125070A5 (US07534539-20090519-C00280.png) 1977-03-30
AT359085B (de) 1980-10-27
IL47149A0 (en) 1975-06-25
BG26369A4 (bg) 1979-03-15
DK158676B (da) 1990-07-02
CS209856B2 (en) 1981-12-31
JPS6012347B2 (ja) 1985-04-01
FI65990B (fi) 1984-04-30
NL183186C (nl) 1988-08-16
DK443077A (da) 1977-10-06
DE2559989C3 (de) 1981-11-19
SE441356B (sv) 1985-09-30
DK442577A (da) 1977-10-06
ATA624977A (de) 1978-12-15
NO751504L (US07534539-20090519-C00280.png) 1975-10-30
AT359084B (de) 1980-10-27
EG11847A (en) 1979-06-30
SE430164B (sv) 1983-10-24
ES453306A1 (es) 1977-11-16
CS209858B2 (en) 1981-12-31
DK159654B (da) 1990-11-12
SU747419A3 (ru) 1980-07-23
DK159267B (da) 1990-09-24
CS209855B2 (en) 1981-12-31
ATA624877A (de) 1980-03-15
ES436986A1 (es) 1977-06-16
JPS514121A (US07534539-20090519-C00280.png) 1976-01-14
DK159267C (da) 1991-02-18
CH624098A5 (US07534539-20090519-C00280.png) 1981-07-15
ES453304A1 (es) 1977-11-16
DD122377A5 (US07534539-20090519-C00280.png) 1976-10-05
DK155520C (da) 1989-10-16
AR217236A1 (es) 1980-03-14
CH621334A5 (US07534539-20090519-C00280.png) 1981-01-30
DE2559989B1 (de) 1981-02-05
DK155672B (da) 1989-05-01
PL111745B1 (en) 1980-09-30
NO149036B (no) 1983-10-24
SE7504828L (sv) 1975-10-30
DK442377A (da) 1977-10-06
AT374484B (de) 1984-04-25
DK442677A (da) 1977-10-06
FR2279388A1 (fr) 1976-02-20
DK442777A (da) 1977-10-06
FI751256A (US07534539-20090519-C00280.png) 1975-10-30
NL7505075A (nl) 1975-10-31
ES453305A1 (es) 1977-11-16
CA1051802A (en) 1979-04-03
DK245783A (da) 1983-05-31
DK155433B (da) 1989-04-10
FR2279388B1 (US07534539-20090519-C00280.png) 1978-07-28
NO149036C (no) 1984-02-01
DE2518160C2 (US07534539-20090519-C00280.png) 1993-05-06
DE2518160A1 (de) 1975-11-20
DK155672C (da) 1989-10-09
DK442977A (da) 1977-10-06
ATA624777A (de) 1980-03-15
SE7812884L (sv) 1978-12-14
BE828546A (fr) 1975-08-18
NO146430B (no) 1982-06-21
GB1504541A (en) 1978-03-22

Similar Documents

Publication Publication Date Title
AT343659B (de) Verfahren zur herstellung von neuen benzimidazol-derivaten und deren saureadditionssalzen
AT340895B (de) Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT359493B (de) Verfahren zur herstellung von neuen n-(4- piperidinyl)-n-phenylamiden und -carbamaten und deren saeuresalzen
AT344683B (de) Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1-aminopropanen und deren saeureadditionssalzen
AT358555B (de) Verfahren zur herstellung von neuen n-amino- alkyl-2-methoxy-benzolsulfonamiden sowie deren saeureadditionssalzen
ATA889476A (de) Verfahren zur herstellung von neuen 1-aryl-2-(1 -imidazolyl)-akylsulfiden, von deren saeure- additionssalzen und optisch aktiven ver- bindungen
AT362366B (de) Verfahren zur herstellung von neuen 5-methyl- -isoxazol-4-carbonsaeureamiden sowie deren salzen
AT351547B (de) Verfahren zur herstellung von neuen thieno- (1,5)-benzodiazepinen und deren saeure- additionssalzen
AT346336B (de) Verfahren zur herstellung von neuen benzimidazol-derivaten und deren salzen
AT361902B (de) Verfahren zur herstellung von neuen amino- saeurederivaten sowie deren salzen und optisch aktiven antipoden
AT355554B (de) Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden
AT344142B (de) Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1-aminopropanen und deren saeureadditionssalzen
AT346303B (de) Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen
AT344712B (de) Verfahren zur herstellung von neuen cinnolin-3-yl-carbonsaeuren und von deren salzen
AT347446B (de) Verfahren zur herstellung von neuen pyrrolidon- derivaten sowie deren salzen
AT340896B (de) Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT342599B (de) Verfahren zur herstellung von neuen indolobenzazepinen und deren saureadditionssalzen
AT338762B (de) Verfahren zur herstellung von neuen substituierten basischen phenolathern sowie deren saureadditionssalzen
AT340897B (de) Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT351509B (de) Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1-phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
AT360010B (de) Verfahren zur herstellung von neuen azabicyclo- alkanen und deren physiologisch vertraeglichen saeureadditionssalzen
AT340894B (de) Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen
AT342021B (de) Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT348979B (de) Verfahren zur herstellung von neuen 7-aminomethylbenzocycloheptenen und deren saeureadditonssalzen
AT357999B (de) Verfahren zur herstellung neuer aminosaeure- derivate und deren salzen sowie optisch aktiven antipoden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee